Skip to content
10-Q

Quarterly Report

PHARMAGREEN BIOTECH INC. PHBI

0001477932-23-000992

← back to feed
Filed
Feb 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Feb 14, 2023 454.76M sh
Operating Cash Flow Q1 2023 · Dec 31, 2022 −$19.5K
Operating Cash Flow Q1 2023 · Dec 31, 2021 −$148.53K
Stockholders Equity Q1 2023 · Dec 31, 2022 −$1.75M
Stockholders Equity Q1 2023 · Sep 30, 2022 −$1.78M
Current Liabilities Q1 2023 · Dec 31, 2022 $1.92M
Current Liabilities Q1 2023 · Sep 30, 2022 $1.91M
Total Liabilities Q1 2023 · Dec 31, 2022 $2.01M
Total Liabilities Q1 2023 · Sep 30, 2022 $2.03M
Total Assets Q1 2023 · Dec 31, 2022 $211.67K
Total Assets Q1 2023 · Sep 30, 2022 $208.97K
Sga Expense Q1 2023 · Dec 31, 2022 $17.76K
Sga Expense Q1 2023 · Dec 31, 2021 $27.21K
Net Income Q1 2023 · Dec 31, 2022 −$39.37K
Net Income Q1 2023 · Dec 31, 2021 $18.72K
Operating Income Q1 2023 · Dec 31, 2022 −$181.09K
Operating Income Q1 2023 · Dec 31, 2021 −$203.66K